NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...
NanoVax Herpes Simplex Virus Vaccine
NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. Read more...
NasoVAX Influenza Vaccine
NasoVAX is a recombinant intranasal vaccine that is RD-Ad5-based, being developed for both seasonal and pandemic use, possibly including COVID-19.Read more...
NEO-PV-01 Cancer Vaccine
NEO-PV-01 Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...
NeoVax Cancer Vaccine
NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...
Nipah Virus Vaccine (PHV02)
Nipah virus vaccine candidate PHV02 is a novel recombinant vaccine that uses a modified rabies virus vector and incorporates a gene from the Nipah virus Read more...
Nirsevimab RSV Monoclonal Antibody
Nirsevimab RSV Monoclonal Antibody is a candidate that is a first-in-class single-dose immunization to provide protection for all infants entering their first RSV seasonRead more...
nOPV2 Polio Vaccine
nOPV2 Polio Vaccine is derived from the live, infectious virus that has been triple-locked using genetic engineering to prevent it from becoming harmfulRead more...
Novavax COVID-19 Vaccine
Novavax's COVID-19 vaccine is a protein-based vaccine engineered from the first strain of SARS-CoV-2.Read more...
